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In American cutaneous leishmaniasis (ACL) , Leishmania para-
sites enter the epidermis of the host via the bite of infected 
sandflies. Immune responses against the parasite vary from 
"effective" in localized (LCL) to a state of "selective anergy" 
in diffuse (DCL) cutaneous leishmaniasis, whereas the inter-
mediate muco-cutaneous form (MCL) is characterized by an 
exacerbated cell-mediated immunity. We have shown that in 
LCL epidermis, Langerhans cells (LC) are increased, HLA-
DR is universally expressed and intercellular adhesion mole-
cule-I (ICAM-I) immunoreactivity is distributed in patches. 
In addition, mRNA for IL-1P, IL-8, TNFa, TNFP, and INFy 
may be detected in epidermal sheets by reverse transcriptase 
followed by polymerase chain reaction (RT -PCR). In con-
trast, DCL epidermis shows fewer LC than LCL epidermis, 
and expression of ICAM-1, HLA-DR, and IL-1P mRNA 
L eishmaniasis is produced by flagellated protozoa of the genus Leishmania, which are obligate intracellular para-sites of phagocytic cells. The disease is transmitted by the bite of female sandflies of the Phlebotominae subfa-mily. In the New World, the multiple strains of Leish-
mania parasites can ~e distingui~hed biochemically. a~d immuno-
chemically, suggestmg an active state of speCiatIOn, which, 
combined with the genetic background of the host, contribute to 
the wide range of clinical forms of the disease. American cutaneous 
leishmaniasis (ACL) is a chronic granulomatous disease with a spec-
trum of clinical manifestations. In localized cutaneous leishmaniasis 
(LCL), the most common form, ~n ade<;Iuate c~ll-mediated immune 
response is mounted, and t~le disease IS restnc.ted to ~e.ll-defined 
skin lesions. In contrast, diffuse cutaneous ietshmamaSlS (DCL), 
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cannot be detected. MCL lesions show a mucosal epithelium 
lacking LC, but ICAM-1 is universally expressed. The clini-
cal manifestations of ACL can be reproduced experimentally 
in different strains of inbred mice. In healthy mice, we have 
shown a positive correlation between LC and dendritic epi-
dermal T cells (DETC) numbers. This correlation was not, 
however, observed in L. mexicana -infected mice, suggesting 
that infection alters the balance between the two cell types. In 
addition, agents that modulate LC and DETC cell densities 
change the development of experimental leishmaniasis. 
These results suggest that the epidermis is essential in deter-
mining the type of immune response that is developed 
against the Leishmania parasites. ] Invest Dermato! 99:95S-
98S, 1992 
which occurs infrequently, is characterized by selective anergy in 
cell-mediated immunity, resulting in extensive involvement of the 
skin, naso-bucopharyngeal mucous tissue, and some lymph nodes 
[1-4]. Some ACL patients develop muco-cutaneous leishmaniasis 
(MeL), which is characterized by exacerbated cell-mediated immu-
nity and destructive lesions of the oral and nasopharyngeal cavities 
[2-4]. These variations in the immune response to parasites in 
human hosts, and the existence of experimental models in different 
inbred strains of mice, have made leishmaniasis an excellent proto-
type for studying the immunoregulatory processes involved in in-
fectious diseases. 
Because the parasite is injected into the epidermis by the sandfly, 
it is reasonable to propose that epidermal immunocompetent cells 
playa role in eliminating the protozoan. In this respect, Langerhans 
cells (LC) may playa critical role in this local response as targets of 
the parasite, because they can be infected in vitro [5]. 
EPIDERMAL LANGERHANS CELLS IN ACL 
Previous work by our group has shown that the numbers of epider-
mal LC are often increased in ACL lesions [6-9], although this 
varies significantly among its three clinical forms. Thus, epidermal 
LC are increased in LCL (Fig 1), and numerous large CDla+ cells 
are also found in the granulomas of these patients. In contrast, the 
density ofLC in DCL is variable, with values that are higher than in 
normal skin but lower than in LCL [6,7] . Finally, LC (CDla+ cells) 
are absent from the mucosal epithelium in MCL lesions [9]. This 
latter finding may reflect the selective migration of antigen-primed 
LC from the epithelium to regional lymph nodes, or may be the 
result of a direct cytolytic effect of the parasite. In this re-
spect, similar results have been observed in virally induced mucosal 
lesions [10]. 
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Figure L Langerhans cells in localized cutane~us leishmaniasis.A?undant 
CD h+ cells present in the epidermis of these lesIOns. AVldm-blOtm Immun-
operoxidase staining. Bar, 20 11m. 
EPIDERMAL LANGERHANS CELLS IN MURINE 
CUTANEOUS LEISHMANIASIS 
Murine models of cutaneous leishmaniasis have been used widely 
and, depending on the Leishmania strain, inoculum size, and mouse 
strain, it has been possible to reproduce the clinical forms observed 
in humans. Thus, BALB/c mice develop lesions similar to DCL; 
C57BL/6 mice are intermediately resistant, reproducing LCL-
like lesions; and DBA mice show intermediate forms of the disease 
[11 - 13]. 
We have studied epidermal LC in L. mexicana-infected BALB/c 
and C57BL/6 mice using the NLDC-145 antibody and immuno-
staining techniques [7]. Healthy BALB/c mice ordinarily have 
more epidermal LC (1300 LC/mm2) than C57BL/6 mice 
(700 LC/mm2), the latter values being similar to those found in 
normal human skin. The high density ofLC in susceptible BALB/c 
mice may contribute to their failure to eliminate the parasite, possi-
bly due to excessive numbers of target cells. L. mexicana - infected 
BALB/c mice showed an increase in the numbers of epidermal LC, 
reaching maximal values on the third (2106 ± 31 cells/mm2) and 
fifth (2196 ± 34 cells/mm2) weeks after infection. These values 
then decreased after the ninth week and reached normal values by 
the eleventh week. In intermediate-resistant C57BL/6 mice, LC 
increased from the time of inoculation and for the first 5 weeks, 
reaching a maximal values (1284 ± 29 cells/mm2) by the third 
week. 
The observed increase in epidermal LC in both human and experi-
mental leishmaniasis suggests the involvement of these cells, al-
though whether they serve as antigen-presenting cells or target cells 
has yet to be determined. 
HLA-DR, ICAM-l, AND CYTOKINE PROFILE IN THE 
EPIDERMIS OF ACL 
LC, epidermal T cells (including yo T cells), and keratinocytes all 
participate in pathologic skin conditions. Interferon-y (INFy), 
major histocompatibility complex class II molecules (HLA-DR) , 
and adhesion molecules, such as LFA-1 and its ligand, ICAM-1, are 
key participants in these processes. Not only are adhesion molecules 
also cited with immigration of lymphocytes into the epidermis, it is 
likely that once T cells and antigen-presenting cells (APC) interact, 
INFy is produced. This lymphokine, in turn, induces the keratino-
cytes to express HLA-DR and ICAM-1 [14,15]. These two mole-
cules, and cytokines such as interleukin (IL)-1 , IL-3, IL-6, IL-8, 
TNFo:, TNF/3, and granulocyte monocyte colony-stimulating fac-
tor (GM-CSF), presumably produced by LC and keratinocytes, 
would then promote the immune response. 
We have studied the expression ofICAM-1 and HLA-DR in the 
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Figure 2. I CAM-l immunostaining in the epidermis oflocalized cutaneous 
leishmaniasis. Positive cells are organized in patches through out the epider-
mis. Bar, 20 11m. 
epidermis of patients with ACL. In addition, we have determined 
lymphokine profiles in epidermal sheets for ACL patients, using a 
reverse transcriptase polymerase chain reaction (RT-PCR). In pa-
tients with LCL, HLA-DR was universally expressed throughout 
the epidermis, whereas ICAM-1 was distributed in patches (Fig 2), 
as has also been described for other cutaneous disorders [16] . In 
disseminated DCL, HLA-DR expression was restricted to LC, and 
ICAM-1 immunoreactivity was absent. In the hypereactive MCL 
epidermis, both HLA-DR and ICAM-1 were universally expressed. 
Using the RT -PCR, we have identified INFy mRNA transcripts in 
epidermal sheets ofLCL and DCL. IL-1P mRNA was expressed in 
LCL epidermis but absent in most DCL samples. INFy has been 
identified as a potent macrophage-activating factor, involved in the 
killing of the Leishmania parasite, and as an important factor in 
selecting a TH 1 response [17]. Thus, one would expect to find high 
levels ofINFy in LCL patients and resistant mice, and low levels of 
INFy in patients with active visceral leishmaniasis or in DCL-
susceptible mice [18,19]. The presence ofINFy in DCL lesions may 
contribute to the lack of message for IL-1/3 in these patients, because 
INFy is known to downregulate IL-1 production [20] . In LCL epi-
dermis, we have also identified mRNA transcripts for TNFa, 
TNF/3, and IL-8, but not for IL-6.* These results demonstrate that 
LCL epidermis has the majority of the components associated with 
an active inflammation. 
T CELLS IN THE EPIDERMIS OF ACL 
In LCL and MCL, we have observed a selective accumulation ofT 
cells towards the basal layer of the epidermis. Phenotypically, these 
CD3+ T cells are either CD4+ or CD8+. We have shown that most 
infiltrating T cells express the aft T-cell receptor (TCR) with only a 
few cells expressing the yo TCR (Fig 3). In DCL lesions, one ob-
serves more yo T cells in the granulomas than in LCL lesions; 
however, few of these cells were observed in the epidermis. 
Dendritic epidermal T cells (DETC) are murine yo T lympho-
cytes that reside normally in epidermis [21], and the LC/DETC 
ratio has correlated with the intensity of contact hypersensitivity 
reaction in mice [22] . We have evaluated LC/DETC ratios in mur-
ine models of leishmaniasis, as a criterion for determining the epi-
dermal participation in the immune response. t In healthy BALB/ c 
• C:lceres-Dittmar G, Sanchez MA, Tapia FJ: Cytokine profiles in the 
epidermis of American cutaneous leishmaniasis using polymerase chain reac-
tion (unpublished). 
t Sanchez MA, C:lceres-Dittmar G, Oriol 0, Mosca W , Kraal G, Tapia 
FJ: Epidermal Langerhans cells and dendritic epidermal T Cells in murine 
cutaneous leishmaniasis (unpublished). 
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Figure 3. Infiltrating. T lymphocytes in localized cutaneous leishmaniasis. 
A selective accumulation o.f a.P ! cells are obs~rved toward the basal layer 
of the epidermis. AVldll1-blOtll1lmmunoperoxldase and {IF! antibody. Bar, 
ZOJ1.m. 
nd C57BL/6 mice, the density of LC and DETC are positively 
~orrelated, and our results show that both cell types increase after 
Leishl1latlia infec.tion (Fig 4). However, ma.ximal numbers of LC 
ppear in the third week, whereas the maximal values for DETC 
:ppear in the fifth week. This difference in triggering suggests that 
LC may present parasite antigens to DETC (and other T cells), 
inducing them to proliferate several days later. In addition, al-
though absolute numbers of LC were always higher than DETC, 
the increase associated with infection was for the latter, emphasiz-
ing their role in experimental leishmaniasis. These changes may 
result from direct involvement of LC and DETC, or as a conse-
quence of the underlying granuloma. Giannini [23] , using 
B 10.129(lOM) mice and L. major parasites, showed that low doses 
ofUVB applied locally to the inoculation site suppressed the devel-
o ment of skin lesions. However, she observed that although UVB a~ected epidermal cells it did not alter the parasite load, concluding 
that local epidermal pertubation during initial phases ofleishmanial 
infection influences both the immunologic response to the parasite 
and the subsequent development of clinical disease. 
Work in our laboratory has also shown important changes in the 
development of skin lesions in L. l1lexicatla-infected C57BL/6 
mice after treatment with prednisolone acetate, tape-stripping, and 
monobenzyl ether of hydroquinone (MBEH).t After treatment 
with MBEH, which increases LC but not DETC, animals become 
more resistant, and lesions heal faster. The steroid depletes both 
epidermal LC and DETC and, ~lthough this exacerbates the diseas~, 
steroids probably affect other Immunocompetent cells as well. FI-
nally, tape-stripping, which depletes the epidermis of both cell 
types, leads to faster healing, suggesting that it may restore a lost 
balance between LC and DETC, which is necessary for protective 
immunity. An alternative interpretation is that the depletion ofLC 
by tape-stripping eliminates target cells for the parasite. 
In summary, the epidermal component of the skin immune sys-
tem participates in the immunoregulatory mechanisms involved in 
human and experimental ACL. The cascade of events that occurs in 
inflammatory reactions involving LC, release of interacting cyto-
kines, migration of T cells, and other inflammatoty cells, and the 
subsequent expression of adhesion molecules, is altered in the dis-
seminated form of leishmaniasis, whereas it is more appropriate in 
the localized forms. The understanding of the epidermal involve-
t Oriol 0 , Sanchez MA, Caceres-Dittmar G, Kraal G, Tapia FJ: Modula-
tion of epidermal cell densiry alters the course of Leish matI ia infection in 
mice (unpublished) . 
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Figure 4. NLDC-145+ Langerhans cells (A), and Thy-1.2+ dendritic epi-
dermal T cells (B), in murine cutaneous leishmaniasis. Avidin-biotin im-
munoperoxidase in EDT A-separated epidermis (9 weeks post-infection) . 
Bar, 10 J1m. 
mellt in cutaneous leishmanias is will help in the development of 
new therapeutic and prophylactic schemes. 
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